Hosted on MSN11mon
AbbVie reports findings from giant cell arteritis therapy trialin combination with a steroid taper regimen in adults with giant cell arteritis (GCA). The multicentre, randomised, double-blind, placebo-controlled trial enrolled 428 patients. Divided into two ...
Giant cell arteritis, or GCA, is a condition where arteries in the head and neck become inflamed. It is called ‘giant cell’ because abnormally large cells accumulate in the artery walls.
double-blind placebo-controlled study designed to evaluate the safety and efficacy of upadacitinib in 428 patients with GCA. The study consists of two periods. The first period, which is reported ...
EMA committee recommends approval of AbbVie’s upadacitinib to treat adults with giant cell arteritis
EMA committee recommends approval of AbbVie’s upadacitinib to treat adults with giant cell arteritis: North Chicago, Illinois Monday, March 3, 2025, 15:00 Hrs [IST] AbbVie annou ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results